Raymond James Financial »

Protagenic Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Protagenic Therapeutics (PTIX) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Protagenic Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagenic Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagenic Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $13k 10k 1.30
2025-06-30 $4 1 4.00

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)

View all positions for Raymond James Financial

Top funds holding Protagenic Therapeutics

DRW Holdings
FNY Investment Advisers
Citadel Advisors
Geode Capital Management
Raymond James Financial
Tower Research Capital
CoreCap Advisors
Advisor Group Holdings
CWM
Harbor Investment Advisory

View all funds holding Protagenic Therapeutics